Loading...
XSHG
603970
Market cap498mUSD
Dec 05, Last price  
13.10CNY
1D
1.16%
1Q
-5.07%
IPO
33.67%
Name

Sino-Agri Leading Biosciences Co Ltd

Chart & Performance

D1W1MN
XSHG:603970 chart
P/E
17.31
P/S
0.33
EPS
0.76
Div Yield, %
3.44%
Shrs. gr., 5y
Rev. gr., 5y
19.53%
Revenues
10.60b
+1.30%
2,144,799,2052,488,047,6452,875,108,0333,234,190,4733,398,424,8123,503,462,1763,734,627,1724,342,465,2536,640,994,2698,822,111,30711,698,774,53810,459,621,43610,595,818,394
Net income
203m
-9.55%
55,462,00668,723,51880,718,87888,266,99781,717,09090,330,227115,459,384118,876,449132,443,776170,309,383210,315,345224,840,982203,377,446
CFO
307m
P
109,434,900-79,662,70040,413,7340152,218,146518,829,38065,690,394218,901,571352,123,389325,419,0811,535,609,866-919,851,225307,399,564
Dividend
Jun 12, 20240.45 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Sino-Agri Leading Biosciences Co.,Ltd researches, develops, produces, and distributes agrochemicals in China and internationally. It offers insecticides, fungicides, and herbicides. The company was incorporated in 2009 and is headquartered in Beijing, China. Sino-Agri Leading Biosciences Co.,Ltd is a subsidiary of China National Agricultural Means Of Production Group Corporation.
IPO date
Nov 16, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT